Skip to content

PET Imaging of AMPA receptor, Amyloid beta, and Tau

PET Imaging of AMPA receptor, Amyloid beta, and Tau - PAAT study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1030250043
Enrollment
Unknown
Registered
2025-04-28
Start date
2025-01-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mild neurocognitive disorder,amnestic disorder,dementia, etc.

Interventions

None listed

Sponsors

Abe Hiroki
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Neurocognitive impairment group (dementia patients) Patients who meet all of the following criteria are eligible 1)Patients who meet the diagnostic criteria for mild neurocognitive disorder, amnesia, or dementia as defined by ICD-11. 2)Patients who are 18 years of age or older at the time of informd consent 3)Patients whose consent can be obtained in writing from the individual (written consent by a substitute is also acceptable when written consent is not possible due to cognitive impairment). (In this case, a surrogate is defined as an adult and the patient's spouse, parents, siblings, children, relatives living in the same household, a person equivalent to a close relative, or a caregiver who can understand the patient's living environment and needs on a daily basis, in other words, a person who partially shares the social and psychological circumstances of the patient and can represent the patient's wishes and interests.) 4)Gender is not required

Exclusion criteria

Exclusion criteria: Neurocognitive impairment group, Sleep/wakefulness disorder group, Healthy control group Persons who have any of the following will not be included in this study 1)Those with pacemakers or metal objects in the body that are not compatible with 3T MRI 2)Patients with tattoos or art makeup 3)Patients with a strong fear of claustrophobia 4)Those who are pregnant or may be pregnant, and those who are breast-feeding. 5)Others who are deemed inappropriate as research subjects by the physician who is the researcher.

Design outcomes

Primary

MeasureTime frame
Changes over time in AMPA receptor expression density from PET images.

Secondary

MeasureTime frame
Changes over time in tau and Abeta distribution density from PET images.

Contacts

Public ContactHiroki Abe

Yokohama City University Hospital

abhiroki@yokohama-cu.ac.jp+81-45-787-2579

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026